Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation
-
Published:2021-08-03
Issue:1
Volume:23
Page:
-
ISSN:1465-542X
-
Container-title:Breast Cancer Research
-
language:en
-
Short-container-title:Breast Cancer Res
Author:
Ribeiro Guerra Maximiliano, Coignard Juliette, Eon-Marchais Séverine, Dondon Marie-Gabrielle, Le Gal Dorothée, Beauvallet Juana, Mebirouk Noura, Belotti Muriel, Caron Olivier, Gauthier-Villars Marion, Coupier Isabelle, Buecher Bruno, Lortholary Alain, Fricker Jean-Pierre, Gesta Paul, Noguès Catherine, Faivre Laurence, Berthet Pascaline, Luporsi Elisabeth, Delnatte Capucine, Bonadona Valérie, Maugard Christine M., Pujol Pascal, Lasset Christine, Longy Michel, Bignon Yves-Jean, Adenis-Lavignasse Claude, Venat-Bouvet Laurence, Dreyfus Hélène, Gladieff Laurence, Mortemousque Isabelle, Audebert-Bellanger Séverine, Soubrier Florent, Giraud Sophie, Lejeune-Dumoulin Sophie, Limacher Jean-Marc, Chiesa Jean, Fajac Anne, Floquet Anne, Eisinger François, Tinat Julie, Fert-Ferrer Sandra, Colas Chrystelle, Frebourg Thierry, Damiola Francesca, Barjhoux Laure, Cavaciuti Eve, Mazoyer Sylvie, Tardivon Anne, Lesueur Fabienne, Stoppa-Lyonnet Dominique, Andrieu NadineORCID
Abstract
Abstract
Background
Diagnostic ionizing radiation is a risk factor for breast cancer (BC). BC risk increases with increased dose to the chest and decreases with increased age at exposure, with possible effect modification related to familial or genetic predisposition. While chest X-rays increase the BC risk of BRCA1/2 mutation carriers compared to non-carriers, little is known for women with a hereditary predisposition to BC but who tested negative for a BRCA1 or BRCA2 (BRCA1/2) mutation.
Methods
We evaluated the effect of chest X-rays from diagnostic medical procedures in a dataset composed of 1552 BC cases identified through French family cancer clinics and 1363 unrelated controls. Participants reported their history of X-ray exposures in a detailed questionnaire and were tested for 113 DNA repair genes. Logistic regression and multinomial logistic regression models were used to assess the association with BC.
Results
Chest X-ray exposure doubled BC risk. A 3% increased BC risk per additional exposure was observed. Being 20 years old or younger at first exposure or being exposed before first full-term pregnancy did not seem to modify this risk. Birth after 1960 or carrying a rare likely deleterious coding variant in a DNA repair gene other than BRCA1/2 modified the effect of chest X-ray exposure.
Conclusion
Ever/never chest X-ray exposure increases BC risk 2-fold regardless of age at first exposure and, by up to 5-fold when carrying 3 or more rare variants in a DNA repair gene.
Further studies are needed to evaluate other DNA repair genes or variants to identify those which could modify radiation sensitivity. Identification of subpopulations that are more or less susceptible to ionizing radiation is important and potentially clinically relevant.
Funder
Brazilian National Council for the Improvement of Higher Education – CAPES Ligue Contre le Cancer Institut National Du Cancer the comprehensive cancer center SiRIC
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Drooger JC, Hooning MJ, Seynaeve CM, Baaijens MH, Obdeijn IM, Sleijfer S, et al. Diagnostic and therapeutic ionizing radiation and the risk of a first and second primary breast cancer, with special attention for BRCA1 and BRCA2 mutation carriers: a critical review of the literature. Cancer Treat Rev. 2015;41(2):187–96. https://doi.org/10.1016/j.ctrv.2014.12.002. 2. Gray JM, Rasanayagam S, Engel C, Rizzo J. State of the evidence 2017: an update on the connection between breast cancer and the environment. Environ Health. 2017;16(1):94. https://doi.org/10.1186/s12940-017-0287-4. 3. Andrieu N, Easton DF, Chang-Claude J, Rookus MA, Brohet R, Cardis E, et al. Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators’ Group. J Clin Oncol. 2006;24(21):3361–6. https://doi.org/10.1200/JCO.2005.03.3126. 4. Lecarpentier J, Nogues C, Mouret-Fourme E, Stoppa-Lyonnet D, Lasset C, Caron O, et al. Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO). Breast Cancer Res Treat. 2011;130(3):927–38. https://doi.org/10.1007/s10549-011-1655-3. 5. Pijpe A, Andrieu N, Easton DF, Kesminiene A, Cardis E, Nogues C, et al. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK). BMJ. 2012;345:e5660. https://doi.org/10.1136/bmj.e5660.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|